Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2012
12/20/2012CA2839445A1 Methods of producing carbamoyl phosphate and urea
12/20/2012CA2839437A1 Antisense modulation of fibroblast growth factor receptor 4 expression
12/20/2012CA2839427A1 Method for enhancing the production yield of human papillomavirus l1 protein
12/20/2012CA2839418A1 Methods for preparative in vitro cloning
12/20/2012CA2839373A1 New means and methods for producing propanediol
12/20/2012CA2839210A1 Methods and materials for assessing allelic imbalance
12/20/2012CA2839009A1 Rabies virus like particle production in plants
12/20/2012CA2838955A1 Synthetic gene clusters
12/20/2012CA2837875A1 Human fusion proteins comprising interferons and targeted modified ubiquitin proteins
12/20/2012CA2837804A1 Dimeric binding proteins based on modified ubiquitins
12/20/2012CA2837768A1 Automated size selection of nucleic acids
12/20/2012CA2837274A1 Simian adenovirus and hybrid adenoviral vectors
12/19/2012EP2535419A2 Synthetic 5'UTRs, expression vectors, and methods for increasing transgene expression
12/19/2012EP2535418A1 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
12/19/2012EP2535417A1 Plants having increased yield-related traits and a method for making the same
12/19/2012EP2535416A1 Development of phytophthora resistant potato with increased yield
12/19/2012EP2535415A1 Modified nucleotide molecules of xylanase and application thereof
12/19/2012EP2535414A1 Novel glyphosate-n-acetyltransferase (gat) genes
12/19/2012EP2535413A2 Splice switching oligomers for the TNF superfamily receptors and their use in treatment of disease
12/19/2012EP2535412A1 New treatment for muscular dystrophies
12/19/2012EP2535410A1 Aptamer to fgf2 and use thereof
12/19/2012EP2535409A1 Method for producing recombinant virus
12/19/2012EP2535408A1 Microchip for nucleic acid amplification reaction and and process for production thereof
12/19/2012EP2535407A1 MANUFACTURING METHOD FOR MUTANT rpsA GENE AND L-AMINO ACID
12/19/2012EP2535406A1 Meganuclease variants cleaving a DNA target sequence from the human hemoglobin beta gene and uses thereof
12/19/2012EP2535405A1 A recombinant a/astanarg/6:2/2009 m-12-09/d flu virus strain produced by a reverse genetics method from a highly pathogenic donor strain a/chicken/astana/6/05 (h5n1) and a highly reproductive donor strain a/puerto rico/8/34 (h1n1) from the orthomyxoviridae family of the genus influenza virus type a which is deposited in the microorganism collection of the science committee at the ministry of education and science of the republic of kazakhstan state enterprise subsidiary of the scientific research institute for biological safety problems at the republican state enterprise of the national centre for biotechnology of the republic of kazakhstan and can be used in biotechnology for the production of diagnostic and vaccine preparations against a/h5n1 flu
12/19/2012EP2535404A1 Method for acquiring genetically identical gamete from lethal fish haploid-derived germ cell via germ line chimera
12/19/2012EP2535358A1 Radioactive metal-labeled anti-cadherin antibody
12/19/2012EP2535348A1 Applications of the protein muns and the derivates thereof
12/19/2012EP2535346A1 Cellular libraries of peptide sequences (CLiPS) and methods of using the same
12/19/2012EP2535151A1 Actuator apparatus with control device
12/19/2012EP2534951A1 Combating pests with a combination of insecticides and transgenic plants by means of leaf and drench application
12/19/2012EP2534484A1 Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
12/19/2012EP2534264A2 Methods for altering polypeptide expression and solubility
12/19/2012EP2534263A2 Methods and compositions for universal detection of nucleic acids
12/19/2012EP2534262A2 Selective reduction of allelic variants
12/19/2012EP2534255A1 Method of reducing glycosylation of proteins, processes and proteins thereof
12/19/2012EP2534251A1 In vivo gene regulation by the combination of knock- in-teto sequence into the genome and tetracycline-controlled trans-suppressor (tts) protein
12/19/2012EP2534250A2 Improvement of the grain filling of a plant through the modulation of nadh-glutamate synthase activity
12/19/2012EP2534249A2 Method for preparing recombinant glycoproteins with high sialic acid content
12/19/2012EP2534248A1 Selective reduction of allelic variants
12/19/2012EP2534247A1 Whole transcriptome sequencing
12/19/2012EP2534163A1 Targeted genomic modification with partially single-stranded donor molecules
12/19/2012EP2533815A1 Nucleic acid complexes
12/19/2012EP2533763A2 Dermatological, pharmaceutical composition suitable for oligonucleotides
12/19/2012EP2533629A2 Methods and materials for producing transgenic artiodactyls
12/19/2012EP2460880A9 Marker and reagent for detection of human il-17-producing helper t cells, and method for detection of human il-17-producing helper t cells
12/19/2012CN102834527A Artificial mycolic acid membranes
12/19/2012CN102834525A Methods for PCR and HLA typing using raw blood
12/19/2012CN102834524A Manufacturing method for 5-(aminomethyl)-2-chlorothiazole
12/19/2012CN102834522A Process for producing koda using lemna paucicostata
12/19/2012CN102834519A Nucleic acid extraction from complex matrices
12/19/2012CN102834518A Improved recovery of nucleic acids from magnetic glass particles
12/19/2012CN102834517A Polynucleotides encoding nf-yb originating in jatropha and utilization thereof
12/19/2012CN102834516A L-threonine analysis method and l-threonine dehydrogenase
12/19/2012CN102834515A Novel hydrolase protein
12/19/2012CN102834514A Transformation plasmid
12/19/2012CN102834509A Yeast strains producing mammalian-like complex N-glycans
12/19/2012CN102834415A Filler for affinity chromatography and method for isolating immunoglobulin
12/19/2012CN102834370A Method for producing 1-amino-1-alkoxycarbonyl-2-vinylcyclopropane
12/19/2012CN102834106A Methods for producing an immune response to tuberculosis
12/19/2012CN102827952A Primer for detecting coxsackievirus A10 nucleic acid, probe and kit
12/19/2012CN102827942A Npc1 gene mutation detection method and reagent kit
12/19/2012CN102827939A Loop-mediated isothermal amplification (LAMP) primer of genetically modified maize BT11 strain, reagent kit and application of LAMP primer
12/19/2012CN102827938A Primer for diagnosing lung lesions caused by chrysotile and man-made mineral fiber by using RT-PCR method
12/19/2012CN102827937A Primer and probe for detecting relative fusion genes of leukemia and kit of primer and probe
12/19/2012CN102827936A Composition and reagent kid for testing human serum albumin transgenic rice strain 114-7-2
12/19/2012CN102827931A Detection primer for detecting listeria monocytogenes by PCR-pyrophosphate method, kit and detection method
12/19/2012CN102827904A Integration method for extracellular production of exogenous proteins by using escherichia coli
12/19/2012CN102827880A Method for biologically synthesizing fatty alcohol from fatty acyl ACP (acyl carrier protein) reductase
12/19/2012CN102827875A Recombinant adenovirus for expressing mouse nerve growth factors and preparation method thereof
12/19/2012CN102827874A Transgene carrier for changing mouse movement ability and metabolic function by specific expression of PEPCK-C (phosphoenolpyruvate carboxykinase-cytosolic) in skeletal muscle
12/19/2012CN102827873A Cre fusion protein functional test cell and modified Cre fusion protein
12/19/2012CN102827872A Establishment of pitressin V1 receptor stable expression cell line and its application in drug screening
12/19/2012CN102827871A Establishment of P2Y1 stable expression cell line and its application in drug screening
12/19/2012CN102827870A Establishment of ET1 stable expression cell line and its application in drug screening
12/19/2012CN102827869A Establishment of P2Y122 stable expression cell line and its application in drug screening
12/19/2012CN102827868A Establishment of pitressin V2 receptor stable expression cell line and its application in drug screening
12/19/2012CN102827867A Establishment of ET2 stable expression cell line and its application in drug screening
12/19/2012CN102827866A Method for increasing content of rosmarinic acid in red-rooted salvia through transgenosis
12/19/2012CN102827865A Plants having increased yield-related traits and a method for making the same
12/19/2012CN102827864A Recombinant bacillus subtilis CoxA16-VP1 expression vector as well as preparation method and application thereof
12/19/2012CN102827863A Method for accelerating extracellular protein matrix secretion and application thereof
12/19/2012CN102827862A Fast cloning and expression vector containing Thioredoxin protein fusion label
12/19/2012CN102827861A Method for increasing proanthocyanidin content in escherichia coli by cotransformation of brassica juncea gene ANS and brassica carinata BAN
12/19/2012CN102827860A Construction method for double-gene mutation escherichia coli used for secretory expression of recombinant protein
12/19/2012CN102827859A Construction method of etr1 gene containing binary expression vector and application thereof
12/19/2012CN102827858A Quick clone containing GB1 protein fusing label and expression plasmid vector
12/19/2012CN102827857A Plasmid vector of L1 protein coding gene containing human papilloma virus 16 (HPV16) and construction method thereof
12/19/2012CN102827856A Method for improving genetic characteristics in diatom oil production
12/19/2012CN102827855A Nucleotide sequence of food-grade L-arabinose isomerase derived from Pediococcus pentosaceus, and application of food-grade L-arabinose isomerase
12/19/2012CN102827854A Encoding gene of DON degrading enzyme and application thereof
12/19/2012CN102827853A Halogenohydrin dehalogenation enzyme gene mutant and application thereof
12/19/2012CN102827852A Novel Dopa-dioxygenase gene for controlling bougainvillea speetabilis beet pigment synthesis
12/19/2012CN102827851A Ketoreductase gene and application of ketoreductase gene
12/19/2012CN102827850A Short-chain dehydrogenase CPE (Cytopathic Effect) gene, coding enzyme, carrier, recombination engineering bacteria and application
12/19/2012CN102827849A Method for increasing proanthocyanidin content in escherichia coli by cotransformation of brassica juncea gene BAN and DFR
12/19/2012CN102827848A 7alpha-hydroxyl steroid dehydrogenase gene optimized by codon
12/19/2012CN102827847A Codon-optimized 7 beta-hydroxy steroid dehydrogenase gene
12/19/2012CN102827846A Preparation method and application of recombination coxsackie virus B3-type virus-like particles